Preferred Label : Dose-dense AC Followed by Paclitaxel/Trastuzumab Regimen;
NCIt synonyms : Dose-dense AC Followed by Paclitaxel/Trastuzumab; Dose-dense Doxorubicin/Cyclophosphamide Followed by Paclitaxel/Trastuzumab; Dose-dense Adriamycin/Cytoxan Followed by Paclitaxel/Trastuzumab; Dose-dense AC Followed by Paclitaxel-Trastuzumab Regimen;
NCIt related terms : ddAC-TH (Paclitaxel); ddAC-TH (Paclitaxel) (trastuzumab-herw); ddAC-TH (Paclitaxel) (trastuzumab-zerc); ddAC-TH (Paclitaxel) (trastuzumab-anns); ddAC-TH (Paclitaxel) (trastuzumab-dttb); ddAC-TH (Paclitaxel) (trastuzumab-qyyp); ddAC-TH (Paclitaxel) (trastuzumab-pkrb); ddAC-TH (Paclitaxel) (trastuzumab-dkst);
NCIt definition : A regimen consisting of doxorubicin and cyclophosphamide followed by paclitaxel and
trastuzumab, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast
cancer.;
NCIt note : Source: NCCN Guidelines 2017;
NCI Metathesaurus CUI : CL525016;
Codes from synonyms : 129425; 129328; 63526; 128940; 128843; 129231; 129134; 129037;
Origin ID : C138036;
UMLS CUI : C4527343;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
